These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 16721289
1. Intervariability and intravariability of bone morphogenetic proteins in commercially available demineralized bone matrix products. Bae HW, Zhao L, Kanim LE, Wong P, Delamarter RB, Dawson EG. Spine (Phila Pa 1976); 2006 May 20; 31(12):1299-306; discussion 1307-8. PubMed ID: 16721289 [Abstract] [Full Text] [Related]
2. Assay of bone morphogenetic protein-2, -4, and -7 in human demineralized bone matrix. Pietrzak WS, Woodell-May J, McDonald N. J Craniofac Surg; 2006 Jan 20; 17(1):84-90. PubMed ID: 16432413 [Abstract] [Full Text] [Related]
3. Quantification of various growth factors in different demineralized bone matrix preparations. Wildemann B, Kadow-Romacker A, Haas NP, Schmidmaier G. J Biomed Mater Res A; 2007 May 20; 81(2):437-42. PubMed ID: 17117475 [Abstract] [Full Text] [Related]
4. Variability across ten production lots of a single demineralized bone matrix product. Bae H, Zhao L, Zhu D, Kanim LE, Wang JC, Delamarter RB. J Bone Joint Surg Am; 2010 Feb 20; 92(2):427-35. PubMed ID: 20124070 [Abstract] [Full Text] [Related]
5. Content of bone morphogenetic protein-4 in human demineralized bone: relationship to donor age and ability to induce new bone formation. Honsawek S, Dhitiseith D. J Med Assoc Thai; 2005 Sep 20; 88 Suppl 4():S260-5. PubMed ID: 16623039 [Abstract] [Full Text] [Related]
6. Extractable bone morphogenetic protein and correlation with induced new bone formation in an in vivo assay in the athymic mouse model. Honsawek S, Powers RM, Wolfinbarger L. Cell Tissue Bank; 2005 Sep 20; 6(1):13-23. PubMed ID: 15735897 [Abstract] [Full Text] [Related]
7. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix. Behnam K, Murray SS, Brochmann EJ. Connect Tissue Res; 2006 Sep 20; 47(5):271-7. PubMed ID: 17118749 [Abstract] [Full Text] [Related]
8. The effect of crosslinking heparin to demineralized bone matrix on mechanical strength and specific binding to human bone morphogenetic protein-2. Lin H, Zhao Y, Sun W, Chen B, Zhang J, Zhao W, Xiao Z, Dai J. Biomaterials; 2008 Mar 20; 29(9):1189-97. PubMed ID: 18083224 [Abstract] [Full Text] [Related]
9. The in vitro elution of BMP-7 from demineralized bone matrix. Pietrzak WS, Dow M, Gomez J, Soulvie M, Tsiagalis G. Cell Tissue Bank; 2012 Dec 20; 13(4):653-61. PubMed ID: 22200971 [Abstract] [Full Text] [Related]
10. The osteogenic effect of bone morphogenetic protein-2 on the collagen scaffold conjugated with antibodies. Zhao Y, Zhang J, Wang X, Chen B, Xiao Z, Shi C, Wei Z, Hou X, Wang Q, Dai J. J Control Release; 2010 Jan 04; 141(1):30-7. PubMed ID: 19580831 [Abstract] [Full Text] [Related]
11. Alkali-urea extraction of demineralized bone matrix removes noggin, an inhibitor of bone morphogenetic proteins. Behnam K, Brochmann E, Murray S. Connect Tissue Res; 2004 Jan 04; 45(4-5):257-60. PubMed ID: 15763935 [Abstract] [Full Text] [Related]
12. Variability of BMP-2 content in DBM products derived from different long bone. Zhao YJ, Yin G, Liu B, Deng XQ, Cao HY, Liu Y. Cell Tissue Bank; 2024 Jun 04; 25(2):697-703. PubMed ID: 38489016 [Abstract] [Full Text] [Related]
13. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion. Biswas D, Bible JE, Whang PH, Miller CP, Jaw R, Miller S, Grauer JN. Am J Orthop (Belle Mead NJ); 2010 Nov 04; 39(11):531-8. PubMed ID: 21623419 [Abstract] [Full Text] [Related]
14. Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, Sun W, Dai J. Biomaterials; 2007 Feb 04; 28(6):1027-35. PubMed ID: 17095085 [Abstract] [Full Text] [Related]
15. A novel application of high-dose (50kGy) gamma irradiation for demineralized bone matrix: effects on fusion rate in a rat spinal fusion model. Alanay A, Wang JC, Shamie AN, Napoli A, Chen C, Tsou P. Spine J; 2008 Feb 04; 8(5):789-95. PubMed ID: 17996496 [Abstract] [Full Text] [Related]
16. Comparative evaluation of the osteoinductivity of two formulations of human demineralized bone matrix. Takikawa S, Bauer TW, Kambic H, Togawa D. J Biomed Mater Res A; 2003 Apr 01; 65(1):37-42. PubMed ID: 12635152 [Abstract] [Full Text] [Related]
17. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. Chen B, Lin H, Zhao Y, Wang B, Zhao Y, Liu Y, Liu Z, Dai J. J Biomed Mater Res A; 2007 Feb 01; 80(2):428-34. PubMed ID: 17013862 [Abstract] [Full Text] [Related]
18. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Patel VV, Zhao L, Wong P, Pradhan BB, Bae HW, Kanim L, Delamarter RB. Spine J; 2006 Feb 01; 6(4):397-403; discussion 404. PubMed ID: 16825045 [Abstract] [Full Text] [Related]
19. Clinical outcomes and fusion success at 2 years of single-level instrumented posterolateral fusions with recombinant human bone morphogenetic protein-2/compression resistant matrix versus iliac crest bone graft. Dimar JR, Glassman SD, Burkus KJ, Carreon LY. Spine (Phila Pa 1976); 2006 Oct 15; 31(22):2534-9; discussion 2540. PubMed ID: 17047540 [Abstract] [Full Text] [Related]
20. Mechanisms of osteoinduction/chondroinduction by demineralized bone. Glowacki J, Zhou S, Mizuno S. J Craniofac Surg; 2009 Mar 15; 20 Suppl 1():634-8. PubMed ID: 19169155 [Abstract] [Full Text] [Related] Page: [Next] [New Search]